Literature DB >> 28846138

ERAS: Safety checklists, antibiotics, and VTE prophylaxis.

Susan D Moffatt-Bruce1, Brian Hilligoss2, Iahn Gonsenhauser3.   

Abstract

The concept rested on several components that many of us have now tried to adopt or improve on, inclusive of a multidisciplinary team, a multimodal approach to anesthesia and preoperative preparedness, evidence-based approach to care protocols; and a change in management using interactive and continuous audit prior to and post-procedure. This article describes the development of ERAS protocols relative to checklist implementation, antibiotic use, and venous thromboembolism (VTE) prevention, how these ideas are developed and operationalized as well as how they are evolving and spreading across the care continuum to achieve sustained outcome improvements.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  VTE prophylaxis; antibiotic use; checklist

Mesh:

Substances:

Year:  2017        PMID: 28846138     DOI: 10.1002/jso.24790

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  3 in total

1.  Influences on surgical antimicrobial prophylaxis decision making by surgical craft groups, anaesthetists, pharmacists and nurses in public and private hospitals.

Authors:  Courtney Ierano; Karin Thursky; Trisha Peel; Arjun Rajkhowa; Caroline Marshall; Darshini Ayton
Journal:  PLoS One       Date:  2019-11-14       Impact factor: 3.240

2.  VTE Prophylaxis Therapy: Clinical Practice vs Clinical Guidelines.

Authors:  Alisse Nasser; Hadeel Khader; Miral Albandak; Abdallah Damin Abukhalil; Raed Madia; Ni'meh Al-Shami; Hani A Naseef
Journal:  Vasc Health Risk Manag       Date:  2022-09-02

3.  Development of a Patient-Oriented Intervention to Support Patient-Provider Conversations about Unnecessary Lower Back Pain Imaging.

Authors:  Maryam Madani Larijani; Cindy Dumba; Heather Thiessen; Angie Palen; Tracey Carr; Jason R Vanstone; Daryl R Fourney; Collin Hartness; Robert Parker; Gary Groot
Journal:  Int J Environ Res Public Health       Date:  2021-03-09       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.